A Randomized, Double-blind, Placebo-controlled, Dose Response Study of AMG 162 (Denosumab) in Japanese Postmenopausal Osteoporotic Subjects
Clinical trial NCT00306189 · COMPLETED
Trial details
- NCT number
- NCT00306189
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2007-06-01
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.